Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spectroscopy, Near-Infrared | 31 | 2024 | 739 | 3.890 |
Why?
|
Plaque, Atherosclerotic | 27 | 2024 | 1532 | 2.490 |
Why?
|
Coronary Artery Disease | 44 | 2024 | 6403 | 2.060 |
Why?
|
Coronary Vessels | 29 | 2024 | 3095 | 1.860 |
Why?
|
Myocardial Infarction | 120 | 2022 | 11459 | 1.760 |
Why?
|
Nuclear Warfare | 2 | 2020 | 30 | 1.360 |
Why?
|
Ultrasonography, Interventional | 17 | 2024 | 1496 | 1.200 |
Why?
|
Lipids | 17 | 2021 | 3332 | 1.170 |
Why?
|
Circadian Rhythm | 40 | 2006 | 2569 | 1.160 |
Why?
|
Nuclear Weapons | 1 | 2023 | 12 | 0.890 |
Why?
|
Coronary Disease | 36 | 2020 | 5912 | 0.740 |
Why?
|
Anger | 9 | 2016 | 406 | 0.710 |
Why?
|
Global Warming | 1 | 2020 | 79 | 0.660 |
Why?
|
Physical Exertion | 14 | 2015 | 668 | 0.650 |
Why?
|
International Cooperation | 3 | 2023 | 1421 | 0.640 |
Why?
|
Death, Sudden, Cardiac | 20 | 2020 | 1551 | 0.600 |
Why?
|
Platelet Aggregation | 17 | 2001 | 771 | 0.580 |
Why?
|
Professional Role | 1 | 2019 | 313 | 0.530 |
Why?
|
Cardiovascular System | 1 | 2023 | 834 | 0.500 |
Why?
|
Angioscopy | 6 | 2014 | 47 | 0.490 |
Why?
|
Coronary Angiography | 19 | 2017 | 4470 | 0.460 |
Why?
|
Multicenter Studies as Topic | 6 | 2017 | 1700 | 0.460 |
Why?
|
Cardiovascular Diseases | 29 | 2020 | 15498 | 0.430 |
Why?
|
Nifedipine | 15 | 1998 | 221 | 0.420 |
Why?
|
Fibrinolysis | 7 | 2001 | 331 | 0.420 |
Why?
|
Arteriosclerosis | 7 | 2005 | 1056 | 0.400 |
Why?
|
Predictive Value of Tests | 21 | 2024 | 15251 | 0.380 |
Why?
|
Coronary Thrombosis | 10 | 2007 | 440 | 0.380 |
Why?
|
Coronary Stenosis | 4 | 2010 | 794 | 0.360 |
Why?
|
Death, Sudden | 9 | 1997 | 301 | 0.350 |
Why?
|
Atherosclerosis | 9 | 2020 | 3400 | 0.340 |
Why?
|
Angioplasty, Balloon, Coronary | 8 | 2014 | 1725 | 0.320 |
Why?
|
Aspirin | 12 | 2020 | 3127 | 0.320 |
Why?
|
Actins | 1 | 2016 | 2050 | 0.310 |
Why?
|
Humans | 241 | 2024 | 760617 | 0.300 |
Why?
|
Calcium | 3 | 2018 | 5717 | 0.290 |
Why?
|
Rupture, Spontaneous | 6 | 2015 | 362 | 0.290 |
Why?
|
Photosensitizing Agents | 3 | 2008 | 623 | 0.290 |
Why?
|
Diagnostic Imaging | 3 | 2010 | 3527 | 0.290 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2016 | 2546 | 0.280 |
Why?
|
Angina, Unstable | 6 | 2021 | 888 | 0.280 |
Why?
|
Fiber Optic Technology | 1 | 2008 | 290 | 0.280 |
Why?
|
Bioterrorism | 4 | 2007 | 144 | 0.270 |
Why?
|
Angina Pectoris | 15 | 2003 | 959 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.250 |
Why?
|
Electrocardiography | 25 | 2014 | 6346 | 0.250 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2895 | 0.250 |
Why?
|
Stress, Physiological | 3 | 2006 | 1403 | 0.240 |
Why?
|
Middle Aged | 129 | 2021 | 220584 | 0.240 |
Why?
|
Photochemotherapy | 2 | 2008 | 823 | 0.240 |
Why?
|
Risk Factors | 60 | 2020 | 74115 | 0.240 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2916 | 0.230 |
Why?
|
Heart Arrest | 2 | 2014 | 1513 | 0.230 |
Why?
|
Risk | 17 | 2016 | 9604 | 0.230 |
Why?
|
Sexual Behavior | 4 | 2006 | 2187 | 0.230 |
Why?
|
Heart | 8 | 2023 | 4403 | 0.230 |
Why?
|
Myocardial Ischemia | 6 | 1999 | 2110 | 0.220 |
Why?
|
Aged | 91 | 2021 | 169042 | 0.220 |
Why?
|
Ventricular Fibrillation | 6 | 2007 | 534 | 0.220 |
Why?
|
Arterial Occlusive Diseases | 3 | 2006 | 748 | 0.220 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2003 | 174 | 0.210 |
Why?
|
Catheterization | 1 | 2008 | 1428 | 0.210 |
Why?
|
Marijuana Smoking | 2 | 2008 | 258 | 0.210 |
Why?
|
Risk Reduction Behavior | 2 | 2020 | 1110 | 0.200 |
Why?
|
Male | 142 | 2021 | 360358 | 0.200 |
Why?
|
User-Computer Interface | 1 | 2008 | 1397 | 0.200 |
Why?
|
Verapamil | 6 | 2005 | 242 | 0.200 |
Why?
|
Plasminogen Activator Inhibitor 1 | 6 | 2005 | 277 | 0.190 |
Why?
|
Fibrosis | 3 | 2015 | 2045 | 0.190 |
Why?
|
Calcinosis | 4 | 2011 | 1469 | 0.190 |
Why?
|
Exercise | 9 | 1996 | 5886 | 0.190 |
Why?
|
Spectrum Analysis | 1 | 2003 | 452 | 0.190 |
Why?
|
Adrenergic beta-Antagonists | 13 | 2013 | 1241 | 0.180 |
Why?
|
Creatine Kinase | 17 | 2011 | 685 | 0.180 |
Why?
|
Peripheral Vascular Diseases | 1 | 2003 | 488 | 0.180 |
Why?
|
Necrosis | 7 | 2015 | 1610 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10199 | 0.170 |
Why?
|
Tissue Plasminogen Activator | 8 | 2004 | 1163 | 0.170 |
Why?
|
Female | 125 | 2021 | 392148 | 0.170 |
Why?
|
Coronary Circulation | 8 | 2005 | 1569 | 0.170 |
Why?
|
Prognosis | 31 | 2017 | 29600 | 0.170 |
Why?
|
Risk Assessment | 19 | 2020 | 23972 | 0.170 |
Why?
|
Posture | 7 | 1999 | 956 | 0.170 |
Why?
|
Stress, Psychological | 10 | 2012 | 4488 | 0.160 |
Why?
|
Fibrinogen | 8 | 2005 | 887 | 0.160 |
Why?
|
Defibrillators, Implantable | 4 | 2007 | 1483 | 0.160 |
Why?
|
Membrane Proteins | 1 | 2016 | 7847 | 0.160 |
Why?
|
Tachycardia, Ventricular | 6 | 2007 | 1261 | 0.160 |
Why?
|
Acute Coronary Syndrome | 3 | 2020 | 2190 | 0.160 |
Why?
|
Sympathetic Nervous System | 2 | 1995 | 519 | 0.160 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10175 | 0.150 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 1068 | 0.150 |
Why?
|
Prospective Studies | 28 | 2021 | 54360 | 0.150 |
Why?
|
Blood Platelets | 4 | 1992 | 2478 | 0.150 |
Why?
|
Nadolol | 3 | 1994 | 29 | 0.150 |
Why?
|
Autopsy | 5 | 2017 | 1008 | 0.140 |
Why?
|
Weather | 1 | 2018 | 231 | 0.140 |
Why?
|
Cross-Over Studies | 10 | 2012 | 2079 | 0.140 |
Why?
|
Thrombosis | 5 | 2010 | 2943 | 0.140 |
Why?
|
Hypertension | 13 | 2006 | 8529 | 0.140 |
Why?
|
Alcohol Drinking | 6 | 2015 | 4025 | 0.140 |
Why?
|
Embolism | 2 | 2010 | 399 | 0.140 |
Why?
|
Vasoconstrictor Agents | 2 | 2001 | 654 | 0.130 |
Why?
|
Sex | 1 | 1996 | 53 | 0.130 |
Why?
|
Anxiety | 3 | 2016 | 4570 | 0.130 |
Why?
|
Nursing Homes | 2 | 2021 | 1083 | 0.130 |
Why?
|
Stents | 6 | 2015 | 3178 | 0.130 |
Why?
|
Coronary Artery Bypass | 7 | 2016 | 2188 | 0.130 |
Why?
|
Arrhythmias, Cardiac | 7 | 2006 | 2234 | 0.130 |
Why?
|
Carotid Stenosis | 4 | 2006 | 859 | 0.130 |
Why?
|
Perioperative Care | 1 | 2003 | 1037 | 0.130 |
Why?
|
ROC Curve | 3 | 2016 | 3575 | 0.130 |
Why?
|
Policy Making | 1 | 2019 | 541 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 2 | 2007 | 148 | 0.120 |
Why?
|
Thromboxane A2 | 2 | 1992 | 88 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4058 | 0.120 |
Why?
|
Syndrome | 4 | 2007 | 3268 | 0.120 |
Why?
|
Vasodilator Agents | 5 | 2003 | 973 | 0.120 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2020 | 2745 | 0.120 |
Why?
|
Alcoholic Beverages | 2 | 2015 | 264 | 0.120 |
Why?
|
Tea | 3 | 2006 | 287 | 0.120 |
Why?
|
Severity of Illness Index | 11 | 2017 | 15828 | 0.120 |
Why?
|
Cardiac Imaging Techniques | 1 | 2017 | 266 | 0.120 |
Why?
|
Fibrinolytic Agents | 5 | 1999 | 2073 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 587 | 0.120 |
Why?
|
Blood Pressure | 17 | 2005 | 8472 | 0.120 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1995 | 186 | 0.110 |
Why?
|
Aorta | 1 | 2002 | 2041 | 0.110 |
Why?
|
Pyridines | 10 | 1983 | 2874 | 0.110 |
Why?
|
Educational Status | 4 | 2004 | 2509 | 0.110 |
Why?
|
Cocaine | 1 | 1999 | 958 | 0.110 |
Why?
|
Hemostasis | 4 | 2005 | 469 | 0.110 |
Why?
|
Electric Countershock | 3 | 2007 | 532 | 0.110 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 681 | 0.110 |
Why?
|
Public Health | 4 | 2007 | 2669 | 0.110 |
Why?
|
Saphenous Vein | 1 | 2016 | 516 | 0.110 |
Why?
|
Calcium Channel Blockers | 6 | 2003 | 694 | 0.110 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 537 | 0.110 |
Why?
|
Time Factors | 31 | 2015 | 39913 | 0.110 |
Why?
|
Area Under Curve | 2 | 2016 | 1635 | 0.100 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2001 | 577 | 0.100 |
Why?
|
Primary Prevention | 1 | 2020 | 1185 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 2 | 1998 | 1208 | 0.100 |
Why?
|
Hemodynamics | 8 | 2007 | 4160 | 0.100 |
Why?
|
Confidence Intervals | 5 | 2015 | 2925 | 0.100 |
Why?
|
Embolism, Cholesterol | 1 | 2011 | 32 | 0.100 |
Why?
|
Survivors | 3 | 2014 | 2372 | 0.100 |
Why?
|
Vascular Resistance | 4 | 1991 | 930 | 0.100 |
Why?
|
Hyaluronoglucosaminidase | 5 | 1984 | 136 | 0.100 |
Why?
|
Widowhood | 1 | 2012 | 52 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3244 | 0.090 |
Why?
|
Coffee | 2 | 2006 | 592 | 0.090 |
Why?
|
Atenolol | 2 | 2003 | 99 | 0.090 |
Why?
|
Mass Screening | 3 | 2020 | 5424 | 0.090 |
Why?
|
Coronary Vasospasm | 4 | 1983 | 81 | 0.090 |
Why?
|
Acute Disease | 9 | 2006 | 7237 | 0.090 |
Why?
|
Double-Blind Method | 15 | 2008 | 12334 | 0.090 |
Why?
|
Aged, 80 and over | 15 | 2018 | 58894 | 0.090 |
Why?
|
Epinephrine | 8 | 2001 | 792 | 0.090 |
Why?
|
Ultrasonography | 3 | 2021 | 5964 | 0.090 |
Why?
|
Antigens, Human Platelet | 2 | 2001 | 41 | 0.090 |
Why?
|
Adult | 58 | 2015 | 220969 | 0.090 |
Why?
|
Clinical Trials as Topic | 13 | 1999 | 7995 | 0.080 |
Why?
|
Grief | 1 | 2012 | 254 | 0.080 |
Why?
|
Interviews as Topic | 4 | 2001 | 2697 | 0.080 |
Why?
|
Cardiology | 1 | 2020 | 1656 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2270 | 0.080 |
Why?
|
Cause of Death | 4 | 2015 | 3683 | 0.080 |
Why?
|
Follow-Up Studies | 23 | 2020 | 39063 | 0.080 |
Why?
|
Survival Analysis | 9 | 2015 | 10073 | 0.080 |
Why?
|
Diabetic Angiopathies | 2 | 2005 | 803 | 0.080 |
Why?
|
Case-Control Studies | 7 | 2015 | 22148 | 0.080 |
Why?
|
Angioplasty | 1 | 2011 | 355 | 0.080 |
Why?
|
Sexual Dysfunctions, Psychological | 2 | 2000 | 192 | 0.080 |
Why?
|
Adenosine Diphosphate | 7 | 2001 | 422 | 0.080 |
Why?
|
Drinking Behavior | 2 | 2005 | 103 | 0.080 |
Why?
|
Factor VII | 4 | 2004 | 139 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2020 | 2056 | 0.080 |
Why?
|
Estrogens | 1 | 1995 | 1521 | 0.080 |
Why?
|
Hyperlipidemias | 2 | 2006 | 770 | 0.080 |
Why?
|
Antihypertensive Agents | 3 | 2006 | 2016 | 0.070 |
Why?
|
Angina Pectoris, Variant | 6 | 1983 | 53 | 0.070 |
Why?
|
Receptors, Scavenger | 1 | 2007 | 123 | 0.070 |
Why?
|
Dogs | 11 | 1999 | 3838 | 0.070 |
Why?
|
Incidence | 9 | 2018 | 21337 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2006 | 2008 | 0.070 |
Why?
|
Heart Rate | 12 | 1997 | 4180 | 0.070 |
Why?
|
Life Change Events | 1 | 2012 | 952 | 0.070 |
Why?
|
Digoxin | 3 | 1986 | 246 | 0.070 |
Why?
|
Spironolactone | 1 | 1990 | 409 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2016 | 20074 | 0.070 |
Why?
|
Inflammation | 3 | 2022 | 10760 | 0.070 |
Why?
|
Pandemics | 3 | 2021 | 8645 | 0.070 |
Why?
|
United States | 21 | 2021 | 72272 | 0.070 |
Why?
|
Emotions | 3 | 2016 | 2740 | 0.070 |
Why?
|
Recurrence | 10 | 2011 | 8426 | 0.070 |
Why?
|
Sensitivity and Specificity | 6 | 2005 | 14648 | 0.070 |
Why?
|
Proportional Hazards Models | 11 | 2015 | 12447 | 0.070 |
Why?
|
Clinical Enzyme Tests | 3 | 1999 | 113 | 0.060 |
Why?
|
Rupture | 1 | 2007 | 443 | 0.060 |
Why?
|
Cohort Studies | 15 | 2015 | 41457 | 0.060 |
Why?
|
Arousal | 3 | 1999 | 1171 | 0.060 |
Why?
|
Logistic Models | 4 | 2013 | 13245 | 0.060 |
Why?
|
Hemorrhage | 1 | 2017 | 3418 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2001 | 4242 | 0.060 |
Why?
|
Catecholamines | 2 | 1999 | 387 | 0.060 |
Why?
|
Serum Albumin, Bovine | 1 | 2006 | 321 | 0.060 |
Why?
|
Electrocardiography, Ambulatory | 3 | 1999 | 574 | 0.060 |
Why?
|
Prothrombin | 1 | 2005 | 190 | 0.060 |
Why?
|
Tablets, Enteric-Coated | 3 | 1997 | 20 | 0.060 |
Why?
|
Disease Susceptibility | 3 | 2006 | 1788 | 0.060 |
Why?
|
Radionuclide Imaging | 4 | 2005 | 1972 | 0.060 |
Why?
|
Random Allocation | 11 | 1989 | 2392 | 0.060 |
Why?
|
Thrombophilia | 2 | 2004 | 306 | 0.060 |
Why?
|
Coitus | 2 | 2002 | 132 | 0.060 |
Why?
|
Microvessels | 1 | 2008 | 577 | 0.060 |
Why?
|
Interview, Psychological | 3 | 2013 | 809 | 0.060 |
Why?
|
Sweden | 2 | 2018 | 1379 | 0.060 |
Why?
|
Research Design | 3 | 2007 | 6174 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2007 | 18221 | 0.060 |
Why?
|
Marijuana Abuse | 1 | 2008 | 411 | 0.060 |
Why?
|
Porphyrins | 1 | 2006 | 352 | 0.060 |
Why?
|
Treatment Outcome | 12 | 2020 | 64568 | 0.060 |
Why?
|
Heart Failure | 11 | 2004 | 11669 | 0.060 |
Why?
|
Stroke Volume | 9 | 2004 | 5486 | 0.060 |
Why?
|
Hydrocortisone | 3 | 1999 | 1819 | 0.050 |
Why?
|
Coated Materials, Biocompatible | 1 | 2005 | 311 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2005 | 219 | 0.050 |
Why?
|
Prosthesis Design | 1 | 2010 | 2114 | 0.050 |
Why?
|
Carotid Artery, Internal | 1 | 2006 | 445 | 0.050 |
Why?
|
Epidemiologic Studies | 1 | 2006 | 673 | 0.050 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2003 | 78 | 0.050 |
Why?
|
Hydrochlorothiazide | 1 | 2003 | 94 | 0.050 |
Why?
|
Netherlands | 3 | 2012 | 2221 | 0.050 |
Why?
|
Activities of Daily Living | 2 | 1989 | 2417 | 0.050 |
Why?
|
Age Factors | 10 | 2016 | 18381 | 0.050 |
Why?
|
Rabbits | 4 | 2007 | 4770 | 0.050 |
Why?
|
Isoenzymes | 10 | 1989 | 1687 | 0.050 |
Why?
|
Automobile Driving | 1 | 2007 | 441 | 0.050 |
Why?
|
Diabetes Complications | 4 | 2001 | 1315 | 0.050 |
Why?
|
Animals | 24 | 2024 | 168201 | 0.050 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 609 | 0.050 |
Why?
|
Radiology, Interventional | 1 | 2006 | 476 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3410 | 0.050 |
Why?
|
Algorithms | 5 | 2020 | 14018 | 0.050 |
Why?
|
Sex Distribution | 2 | 2004 | 2278 | 0.050 |
Why?
|
Vasodilation | 2 | 2005 | 962 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2009 | 5239 | 0.050 |
Why?
|
Personality Inventory | 2 | 2013 | 1018 | 0.050 |
Why?
|
Beverages | 1 | 2006 | 821 | 0.050 |
Why?
|
Vasculitis | 1 | 2005 | 522 | 0.050 |
Why?
|
Equipment Design | 2 | 2024 | 3501 | 0.040 |
Why?
|
Spectrum Analysis, Raman | 1 | 2002 | 237 | 0.040 |
Why?
|
Life Style | 2 | 2006 | 3904 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 1 | 2002 | 685 | 0.040 |
Why?
|
Propranolol | 5 | 1989 | 490 | 0.040 |
Why?
|
Thromboembolism | 1 | 2006 | 991 | 0.040 |
Why?
|
Terminology as Topic | 2 | 2004 | 1528 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2016 | 12043 | 0.040 |
Why?
|
Reference Values | 4 | 1999 | 4919 | 0.040 |
Why?
|
Thrombolytic Therapy | 4 | 2002 | 2055 | 0.040 |
Why?
|
Caffeine | 1 | 2004 | 699 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2024 | 729 | 0.040 |
Why?
|
Analysis of Variance | 6 | 2006 | 6224 | 0.040 |
Why?
|
Terrorism | 1 | 2002 | 210 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2002 | 943 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2006 | 1009 | 0.040 |
Why?
|
Odds Ratio | 5 | 2006 | 9643 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2002 | 539 | 0.040 |
Why?
|
Prostaglandins | 1 | 1999 | 398 | 0.040 |
Why?
|
Biology | 1 | 2020 | 290 | 0.040 |
Why?
|
Folic Acid | 1 | 2005 | 1323 | 0.040 |
Why?
|
Blood Viscosity | 3 | 2005 | 124 | 0.040 |
Why?
|
Sex Factors | 9 | 2015 | 10548 | 0.040 |
Why?
|
Platelet Activation | 2 | 1999 | 646 | 0.040 |
Why?
|
Nitroglycerin | 5 | 1983 | 329 | 0.040 |
Why?
|
Postmenopause | 2 | 1998 | 2511 | 0.040 |
Why?
|
Time | 2 | 1991 | 545 | 0.040 |
Why?
|
von Willebrand Factor | 4 | 2005 | 676 | 0.040 |
Why?
|
Age Distribution | 1 | 2003 | 2871 | 0.040 |
Why?
|
Myocardial Contraction | 4 | 1983 | 1515 | 0.040 |
Why?
|
Hypobetalipoproteinemias | 1 | 1997 | 11 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2005 | 2650 | 0.040 |
Why?
|
Patient Care | 1 | 2022 | 621 | 0.030 |
Why?
|
Massachusetts | 4 | 2001 | 8833 | 0.030 |
Why?
|
Patient Selection | 2 | 2012 | 4237 | 0.030 |
Why?
|
Heparin | 1 | 1984 | 1632 | 0.030 |
Why?
|
Shock, Cardiogenic | 3 | 1989 | 709 | 0.030 |
Why?
|
Death | 1 | 2021 | 674 | 0.030 |
Why?
|
Norepinephrine | 3 | 1994 | 898 | 0.030 |
Why?
|
Europe | 1 | 2003 | 3413 | 0.030 |
Why?
|
Linear Models | 2 | 2012 | 5866 | 0.030 |
Why?
|
Tachycardia | 3 | 1987 | 597 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3356 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2006 | 6483 | 0.030 |
Why?
|
Chest Pain | 1 | 2002 | 1091 | 0.030 |
Why?
|
Viper Venoms | 1 | 1995 | 15 | 0.030 |
Why?
|
Heart Diseases | 2 | 1996 | 2778 | 0.030 |
Why?
|
Enzyme Precursors | 1 | 1995 | 170 | 0.030 |
Why?
|
Texas | 1 | 2016 | 403 | 0.030 |
Why?
|
Apolipoproteins B | 1 | 1997 | 385 | 0.030 |
Why?
|
Michigan | 1 | 2016 | 339 | 0.030 |
Why?
|
Body Height | 1 | 2001 | 1565 | 0.030 |
Why?
|
Physician's Role | 1 | 2002 | 917 | 0.030 |
Why?
|
Embolic Protection Devices | 1 | 2015 | 42 | 0.030 |
Why?
|
Autonomic Nervous System | 2 | 1997 | 704 | 0.030 |
Why?
|
Myocardium | 10 | 2003 | 4724 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26049 | 0.030 |
Why?
|
Causality | 1 | 2001 | 1240 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2004 | 1402 | 0.030 |
Why?
|
Dreams | 1 | 1996 | 146 | 0.030 |
Why?
|
Creatine Kinase, MB Form | 1 | 2015 | 202 | 0.030 |
Why?
|
Public Health Administration | 2 | 2007 | 241 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 1995 | 224 | 0.030 |
Why?
|
Prevalence | 4 | 2006 | 15689 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1995 | 325 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5758 | 0.030 |
Why?
|
Diuretics | 2 | 2003 | 611 | 0.030 |
Why?
|
Emergencies | 1 | 1980 | 1217 | 0.030 |
Why?
|
Forecasting | 2 | 2020 | 2924 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2006 | 36402 | 0.030 |
Why?
|
Registries | 3 | 2020 | 8207 | 0.030 |
Why?
|
Sleep Stages | 1 | 1997 | 695 | 0.030 |
Why?
|
Rage | 1 | 2013 | 30 | 0.030 |
Why?
|
Vasoconstriction | 3 | 1981 | 592 | 0.030 |
Why?
|
Platelet Count | 3 | 1999 | 780 | 0.030 |
Why?
|
Mental Processes | 1 | 1994 | 243 | 0.030 |
Why?
|
Obesity | 3 | 2004 | 12933 | 0.030 |
Why?
|
Data Collection | 1 | 2002 | 3315 | 0.030 |
Why?
|
Histamine | 1 | 1995 | 499 | 0.030 |
Why?
|
Lipectomy | 1 | 2014 | 113 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 12966 | 0.030 |
Why?
|
Exercise Test | 5 | 1999 | 2127 | 0.030 |
Why?
|
Comorbidity | 3 | 2004 | 10505 | 0.030 |
Why?
|
Advisory Committees | 2 | 2007 | 787 | 0.030 |
Why?
|
Diabetes Mellitus | 5 | 2004 | 5835 | 0.030 |
Why?
|
Insulin | 4 | 2005 | 6593 | 0.030 |
Why?
|
Galvanic Skin Response | 1 | 1994 | 358 | 0.030 |
Why?
|
Demography | 3 | 2004 | 1643 | 0.030 |
Why?
|
Sleep, REM | 1 | 1996 | 595 | 0.030 |
Why?
|
Retrospective Studies | 11 | 2020 | 80566 | 0.030 |
Why?
|
Survival Rate | 4 | 2014 | 12719 | 0.030 |
Why?
|
Statistics, Nonparametric | 3 | 2006 | 2849 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2002 | 3769 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2005 | 3735 | 0.020 |
Why?
|
Streptokinase | 2 | 1983 | 186 | 0.020 |
Why?
|
Cerebrovascular Disorders | 2 | 1989 | 1474 | 0.020 |
Why?
|
Receptors, Adrenergic | 1 | 1992 | 155 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8618 | 0.020 |
Why?
|
Sleep | 3 | 1997 | 4758 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1896 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2006 | 2261 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2017 | 1059 | 0.020 |
Why?
|
Propanolamines | 1 | 1992 | 163 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 1996 | 1335 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 1937 | 0.020 |
Why?
|
Delayed-Action Preparations | 3 | 2003 | 962 | 0.020 |
Why?
|
Epoprostenol | 1 | 1992 | 247 | 0.020 |
Why?
|
Premenopause | 1 | 1995 | 1038 | 0.020 |
Why?
|
Nuclear Family | 1 | 2012 | 311 | 0.020 |
Why?
|
Organ Specificity | 2 | 2006 | 1964 | 0.020 |
Why?
|
Fear | 1 | 1999 | 1477 | 0.020 |
Why?
|
Ventricular Function, Left | 2 | 1995 | 3873 | 0.020 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1228 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2004 | 6807 | 0.020 |
Why?
|
Carbazoles | 1 | 1992 | 220 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
No-Reflow Phenomenon | 1 | 2009 | 16 | 0.020 |
Why?
|
Body Mass Index | 2 | 2004 | 12943 | 0.020 |
Why?
|
Heart Rupture | 1 | 1989 | 21 | 0.020 |
Why?
|
Thrombectomy | 1 | 2014 | 702 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2011 | 15612 | 0.020 |
Why?
|
Electrolytes | 1 | 1990 | 274 | 0.020 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 1989 | 48 | 0.020 |
Why?
|
Hematocrit | 2 | 1988 | 623 | 0.020 |
Why?
|
Hospitalization | 9 | 2013 | 10704 | 0.020 |
Why?
|
Exercise Therapy | 1 | 1996 | 929 | 0.020 |
Why?
|
Metoprolol | 1 | 1989 | 90 | 0.020 |
Why?
|
Kidney Tubules | 1 | 1990 | 449 | 0.020 |
Why?
|
Smoking | 6 | 2004 | 9050 | 0.020 |
Why?
|
Drug Therapy, Combination | 3 | 1990 | 6305 | 0.020 |
Why?
|
Actuarial Analysis | 2 | 2004 | 372 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2012 | 790 | 0.020 |
Why?
|
Wakefulness | 1 | 1995 | 1264 | 0.020 |
Why?
|
History, 19th Century | 2 | 1983 | 718 | 0.020 |
Why?
|
Placebos | 3 | 1996 | 1667 | 0.020 |
Why?
|
Regional Blood Flow | 4 | 2005 | 1496 | 0.020 |
Why?
|
Oxygen Consumption | 4 | 1983 | 1866 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1998 | 2118 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2001 | 794 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 1997 | 2379 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2011 | 20556 | 0.020 |
Why?
|
Air Pollution | 1 | 2001 | 2355 | 0.020 |
Why?
|
Pericarditis | 1 | 1989 | 134 | 0.020 |
Why?
|
Single-Blind Method | 1 | 1991 | 1575 | 0.020 |
Why?
|
Fluorocarbons | 2 | 1983 | 492 | 0.020 |
Why?
|
Troponin I | 1 | 2011 | 650 | 0.020 |
Why?
|
Stroke | 2 | 2006 | 9712 | 0.020 |
Why?
|
Aging | 1 | 2005 | 8699 | 0.020 |
Why?
|
Bundle-Branch Block | 1 | 1988 | 276 | 0.020 |
Why?
|
Chlorophyllides | 1 | 2006 | 54 | 0.020 |
Why?
|
Death Certificates | 1 | 1987 | 167 | 0.020 |
Why?
|
Tissue Polypeptide Antigen | 1 | 2005 | 4 | 0.020 |
Why?
|
Ticlopidine | 1 | 2010 | 730 | 0.020 |
Why?
|
Injections, Intravenous | 3 | 1983 | 1376 | 0.020 |
Why?
|
Cholesterol | 1 | 1995 | 2903 | 0.020 |
Why?
|
Age of Onset | 2 | 2003 | 3302 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 361 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3196 | 0.020 |
Why?
|
Centrifugation | 1 | 2005 | 122 | 0.020 |
Why?
|
Brain Ischemia | 1 | 1999 | 3028 | 0.020 |
Why?
|
Swine | 2 | 2007 | 5907 | 0.020 |
Why?
|
Research | 1 | 1994 | 1977 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2723 | 0.020 |
Why?
|
Nitrates | 2 | 1984 | 263 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2005 | 284 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2002 | 4416 | 0.020 |
Why?
|
Women | 1 | 1987 | 224 | 0.020 |
Why?
|
Schizophrenia | 1 | 2004 | 6929 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2009 | 1835 | 0.020 |
Why?
|
Heart Block | 1 | 1986 | 384 | 0.010 |
Why?
|
Cold Temperature | 3 | 1983 | 784 | 0.010 |
Why?
|
Patient Compliance | 2 | 2005 | 2688 | 0.010 |
Why?
|
Disability Evaluation | 1 | 1991 | 1835 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10754 | 0.010 |
Why?
|
Diltiazem | 2 | 1980 | 131 | 0.010 |
Why?
|
Medicare | 1 | 2021 | 6765 | 0.010 |
Why?
|
Eating | 1 | 1990 | 1535 | 0.010 |
Why?
|
Sleep Deprivation | 1 | 1990 | 847 | 0.010 |
Why?
|
Colorimetry | 1 | 2004 | 150 | 0.010 |
Why?
|
Psychometrics | 1 | 2013 | 3060 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.010 |
Why?
|
Carbonated Beverages | 1 | 2004 | 210 | 0.010 |
Why?
|
Waist-Hip Ratio | 1 | 2004 | 518 | 0.010 |
Why?
|
Emergency Medical Services | 2 | 2002 | 1921 | 0.010 |
Why?
|
History, 20th Century | 2 | 1983 | 2764 | 0.010 |
Why?
|
Diastole | 2 | 1998 | 781 | 0.010 |
Why?
|
Evaluation Studies as Topic | 3 | 1988 | 1623 | 0.010 |
Why?
|
Markov Chains | 1 | 2005 | 965 | 0.010 |
Why?
|
Philosophy, Medical | 1 | 2002 | 79 | 0.010 |
Why?
|
Nuclear Medicine | 1 | 2005 | 237 | 0.010 |
Why?
|
Follicular Phase | 1 | 2002 | 143 | 0.010 |
Why?
|
Health Care Costs | 1 | 1995 | 3238 | 0.010 |
Why?
|
Heart Function Tests | 2 | 1996 | 318 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1970 | 0.010 |
Why?
|
Africa | 1 | 2004 | 710 | 0.010 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 1983 | 223 | 0.010 |
Why?
|
Perhexiline | 1 | 1980 | 5 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2005 | 1370 | 0.010 |
Why?
|
Regression Analysis | 2 | 1992 | 6338 | 0.010 |
Why?
|
Integrin beta3 | 1 | 2001 | 120 | 0.010 |
Why?
|
Oxygen | 2 | 1983 | 4226 | 0.010 |
Why?
|
Family | 1 | 2012 | 3193 | 0.010 |
Why?
|
Cattle | 2 | 2004 | 3841 | 0.010 |
Why?
|
Cardiac Output | 1 | 1983 | 831 | 0.010 |
Why?
|
False Negative Reactions | 3 | 1988 | 573 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13495 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 1418 | 0.010 |
Why?
|
Adenosine | 1 | 2005 | 805 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 2048 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 1998 | 4845 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 1983 | 539 | 0.010 |
Why?
|
False Positive Reactions | 3 | 1988 | 957 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2004 | 802 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 1253 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2007 | 2382 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2005 | 1722 | 0.010 |
Why?
|
Benzazepines | 1 | 1980 | 310 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1407 | 0.010 |
Why?
|
Potassium | 1 | 1983 | 1311 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1978 | 306 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3800 | 0.010 |
Why?
|
USSR | 1 | 1977 | 18 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 981 | 0.010 |
Why?
|
Heart Aneurysm | 1 | 1978 | 114 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1997 | 80 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2002 | 941 | 0.010 |
Why?
|
Carbon | 1 | 2001 | 665 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2004 | 839 | 0.010 |
Why?
|
Hyaluronic Acid | 1 | 1981 | 483 | 0.010 |
Why?
|
Models, Statistical | 1 | 2012 | 5073 | 0.010 |
Why?
|
Particle Size | 1 | 2001 | 1648 | 0.010 |
Why?
|
Heart Ventricles | 5 | 1989 | 3796 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 1997 | 14591 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 2001 | 466 | 0.010 |
Why?
|
Progestins | 1 | 1998 | 301 | 0.010 |
Why?
|
Homozygote | 1 | 2001 | 1776 | 0.010 |
Why?
|
Systole | 1 | 1998 | 935 | 0.010 |
Why?
|
Fourier Analysis | 1 | 1997 | 440 | 0.010 |
Why?
|
Genotype | 2 | 2001 | 12978 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 2 | 1978 | 1092 | 0.010 |
Why?
|
Heart Arrest, Induced | 1 | 1977 | 358 | 0.010 |
Why?
|
Ion Channels | 1 | 1980 | 1039 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2001 | 2340 | 0.010 |
Why?
|
Monitoring, Physiologic | 2 | 1997 | 1779 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2005 | 5491 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13382 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2005 | 1426 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2002 | 1431 | 0.010 |
Why?
|
Seasons | 1 | 2001 | 1518 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2881 | 0.010 |
Why?
|
Isoproterenol | 1 | 1975 | 397 | 0.010 |
Why?
|
Epitopes | 1 | 2001 | 2501 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2005 | 6016 | 0.010 |
Why?
|
Thorax | 1 | 1978 | 555 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2222 | 0.010 |
Why?
|
Mortality | 1 | 2005 | 2899 | 0.010 |
Why?
|
Gene Frequency | 1 | 2001 | 3601 | 0.010 |
Why?
|
Action Potentials | 2 | 1980 | 1825 | 0.010 |
Why?
|
Glycolysis | 1 | 1978 | 835 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11069 | 0.010 |
Why?
|
Consensus | 1 | 2003 | 3117 | 0.010 |
Why?
|
Polymers | 1 | 1981 | 1614 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1984 | 3705 | 0.010 |
Why?
|
Population Surveillance | 1 | 2004 | 2595 | 0.010 |
Why?
|
Phenotype | 2 | 2001 | 16571 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 1983 | 1810 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1978 | 625 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 2000 | 1028 | 0.010 |
Why?
|
Yohimbine | 1 | 1992 | 62 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2005 | 3085 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 1977 | 753 | 0.010 |
Why?
|
Vascular Patency | 1 | 1995 | 911 | 0.010 |
Why?
|
Piperidines | 1 | 1980 | 1655 | 0.010 |
Why?
|
Glucose | 1 | 1983 | 4345 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1992 | 1141 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 1997 | 1810 | 0.010 |
Why?
|
Probability | 2 | 1987 | 2475 | 0.010 |
Why?
|
Alleles | 1 | 2001 | 6861 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2001 | 17878 | 0.010 |
Why?
|
Triglycerides | 1 | 1997 | 2459 | 0.010 |
Why?
|
Adolescent | 4 | 2004 | 88234 | 0.010 |
Why?
|
Genetic Testing | 1 | 2001 | 3533 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13441 | 0.000 |
Why?
|
Heart Septum | 1 | 1989 | 299 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 7389 | 0.000 |
Why?
|
Collagen | 1 | 1996 | 2634 | 0.000 |
Why?
|
Models, Biological | 1 | 2004 | 9461 | 0.000 |
Why?
|
Anticoagulants | 1 | 1983 | 4785 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 8998 | 0.000 |
Why?
|
Mutation | 2 | 2001 | 30016 | 0.000 |
Why?
|
Rats | 2 | 1983 | 23717 | 0.000 |
Why?
|
Renin | 1 | 1988 | 640 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6520 | 0.000 |
Why?
|
Diphosphates | 1 | 1985 | 84 | 0.000 |
Why?
|
Angiotensin II | 1 | 1988 | 849 | 0.000 |
Why?
|
Bradycardia | 1 | 1986 | 299 | 0.000 |
Why?
|
Mathematics | 1 | 1985 | 707 | 0.000 |
Why?
|
Sodium Pertechnetate Tc 99m | 1 | 1983 | 54 | 0.000 |
Why?
|
Technetium | 1 | 1983 | 317 | 0.000 |
Why?
|
Methods | 1 | 1983 | 1065 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1994 | 2768 | 0.000 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1986 | 763 | 0.000 |
Why?
|
Phentolamine | 1 | 1981 | 102 | 0.000 |
Why?
|
Blood Gas Analysis | 1 | 1982 | 379 | 0.000 |
Why?
|
Pressoreceptors | 1 | 1981 | 99 | 0.000 |
Why?
|
Hypotension | 1 | 1986 | 878 | 0.000 |
Why?
|
Nitrogen | 1 | 1980 | 345 | 0.000 |
Why?
|
Spasm | 1 | 1979 | 130 | 0.000 |
Why?
|
Guinea Pigs | 1 | 1980 | 1310 | 0.000 |
Why?
|
Molecular Weight | 1 | 1981 | 2185 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1988 | 2090 | 0.000 |
Why?
|
Electrophysiology | 1 | 1980 | 1262 | 0.000 |
Why?
|
Biological Transport | 1 | 1982 | 2089 | 0.000 |
Why?
|
Testis | 1 | 1981 | 792 | 0.000 |
Why?
|
Injections, Intradermal | 1 | 1977 | 116 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1980 | 1463 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1977 | 411 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1977 | 414 | 0.000 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1979 | 852 | 0.000 |
Why?
|
Child | 1 | 2004 | 80079 | 0.000 |
Why?
|
Sodium | 1 | 1980 | 1588 | 0.000 |
Why?
|
Heart Conduction System | 1 | 1980 | 992 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1980 | 1988 | 0.000 |
Why?
|
Hot Temperature | 1 | 1981 | 1437 | 0.000 |
Why?
|
Infant | 1 | 1996 | 36152 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1976 | 1333 | 0.000 |
Why?
|